Find clinical documents

or

Document type:
RAG rating:question mark
Place:
Output type:
Medicine / Guideline Indication RAG rating Document type Place
Acetylcholinesterase (AChE) inhibitor Alzheimer's disease dementia Amber initiation Prescribing support document East and North Hertfordshire, South and West Hertfordshire
Acetylcholinesterase (AChE) inhibitor Alzheimer's disease dementia Amber protocol Shared care protocol West Essex
Alemtuzumab Highly active relapsing remitting multiple sclerosis (NHSE) Red NICE technology appraisal Hertfordshire and West Essex ICB
Anticholinergic burden (ACB) Structured medication review Eclipse Live n/a Primary Care prescribing resource Hertfordshire and West Essex ICB
Anticholinergic burden (ACB) Structured medication review Hints and tips n/a Primary Care prescribing resource Hertfordshire and West Essex ICB
Atomoxetine Attention deficit hyperactivity disorder (ADHD) adult Amber protocol Shared care protocol West Essex
Atomoxetine Attention deficit hyperactivity disorder (ADHD) Amber protocol Shared care protocol East and North Hertfordshire, South and West Hertfordshire
Attention deficit hyperactivity disorder (ADHD) FAQs n/a Primary Care prescribing resource South and West Hertfordshire
Attention deficit hyperactivity disorder (ADHD) ADHD shared care protocol - adult Amber protocol Shared care protocol West Essex
Attention deficit hyperactivity disorder (ADHD) ADHD shared care protocol - children, young people and adults Amber protocol Shared care protocol East and North Hertfordshire, South and West Hertfordshire
Bobath Therapy n/a Clinical policy Hertfordshire and West Essex ICB
Botulinum toxin type A Focal spasticity, Hemi-facial spasm, Blepharospasm, Cervical dystonia, Frey’s syndrome, Chronic anal fissure, Dysphagia, Hirschsprung’s disease, Overactive bladder,Masseteric hypertrophy and temporomandibular disorders Red Prescribing guideline Hertfordshire and West Essex ICB
Cannabis-based medicinal preparations Intractable nausea & vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy Red Position statement Hertfordshire and West Essex ICB
Cenobamate Focal onset seizures Amber initiation NICE technology appraisal Hertfordshire and West Essex ICB
Cladribine Relapsing–remitting multiple sclerosis (NHSE) Red NICE technology appraisal Hertfordshire and West Essex ICB
Co-careldopa (Carbidopa/levodopa) intestinal gel Parkinson's disease (NHSE) Red Decision document Hertfordshire and West Essex ICB
Co-careldopa Intestinal Gel (Duodopa) Parkinson's Disease (NHSE tertiary centre only) Red n/a Hertfordshire and West Essex ICB
Co-proxamol Pain Double Red Prescribing guideline Hertfordshire and West Essex ICB
Cytisine Smoking cessation Double Red Decision document Hertfordshire and West Essex ICB
Daridorexant Insomnia Green NICE technology appraisal Hertfordshire and West Essex ICB
Daridorexant Long-term insomnia Green Patient information Hertfordshire and West Essex ICB
Daridorexant Long-term insomnia Green Prescribing support document Hertfordshire and West Essex ICB
Dependence forming medicine Pain - ECF FAQs n/a Primary Care prescribing resource Hertfordshire and West Essex ICB
Dexamfetamine Attention deficit hyperactivity disorder (ADHD) adult Amber protocol Shared care protocol West Essex
Dexamfetamine Attention deficit hyperactivity disorder (ADHD) Amber protocol Shared care protocol East and North Hertfordshire, South and West Hertfordshire
Domperidone Nausea vomiting in children Double Red Prescribing guideline Hertfordshire and West Essex ICB
Donepezil Alzheimer's disease dementia Amber protocol Shared care protocol West Essex
Drug Titration and Review for Neuropathic Pain n/a Clinical pathways Hertfordshire and West Essex ICB
Electronic Cigarettes and other novel nicotine containing products Tobacco dependance Red Position statement Hertfordshire and West Essex ICB
Epilepsy, Fits and Seizures n/a Clinical pathways Hertfordshire and West Essex ICB
Eptinezumab Migraine - chronic Red Prescribing pathway Hertfordshire and West Essex ICB
Eptinezumab Migraine - episodic Red Decision document Hertfordshire and West Essex ICB
Erenumab Migraine - chronic Red Prescribing pathway Hertfordshire and West Essex ICB
Erenumab Migraine - episodic Red Prescribing pathway Hertfordshire and West Essex ICB
Ethosuximide Absence seizures, atypical absence seizures (adjunct) and myoclonic seizures in adults and children. Amber initiation Prescribing support document Hertfordshire and West Essex ICB
Ethosuximide capsules Absence seizures, atypical absence seizures (adjunct) and myoclonic seizures in adults and children. Amber initiation Primary Care prescribing resource Hertfordshire and West Essex ICB
Ethosuximide syrup Absence seizures, atypical absence seizures (adjunct) and myoclonic seizures in adults and children. Amber initiation Primary Care prescribing resource Hertfordshire and West Essex ICB
Fampridine Multiple sclerosis (NHSE) Double Red Decision document Hertfordshire and West Essex ICB
Fentanyl immediate release (IR) Pain (except for palliative care) Double Red Prescribing guideline Hertfordshire and West Essex ICB
Fingolimod Highly active relapsing–remitting multiple sclerosis (NHSE) Red NICE technology appraisal Hertfordshire and West Essex ICB
Fremanezumab Migraine - chronic Red Prescribing pathway Hertfordshire and West Essex ICB
Fremanezumab Migraine - episodic Red Prescribing pathway Hertfordshire and West Essex ICB
Galantamine Alzheimer's disease dementia Amber protocol Shared care protocol West Essex
Galcanezumab Migraine - chronic Red Prescribing pathway Hertfordshire and West Essex ICB
Galcanezumab Migraine - episodic Red Prescribing pathway Hertfordshire and West Essex ICB, East and North Hertfordshire, South and West Hertfordshire, West Essex
Glatiramer Multiple sclerosis (NHSE) Red NICE technology appraisal Hertfordshire and West Essex ICB
Glycopyrronium bromide oral Hypersalivation Double Red Decision document Hertfordshire and West Essex ICB
Headache n/a Clinical pathways Hertfordshire and West Essex ICB
Lisdexamfetamine Attention deficit hyperactivity disorder (ADHD) adult Amber protocol Shared care protocol West Essex
Lisdexamfetamine Attention deficit hyperactivity disorder (ADHD) Amber protocol Shared care protocol East and North Hertfordshire, South and West Hertfordshire
Long term insomnia management Long-term insomnia Green Patient information Hertfordshire and West Essex ICB
Mechanical Insufflation-Exsufflation (MI-E) Devices / CoughAssist n/a Clinical policy Hertfordshire and West Essex ICB
Melatonin Insomnia - Neurodevelopmental Disorders in patients under the age of 18 years Amber initiation Prescribing support document Hertfordshire and West Essex ICB
Melatonin Insomnia - Learning disability in adults and paediatrics Amber initiation Prescribing support document Hertfordshire and West Essex ICB
Melatonin Insomnia - product options in neurodevelopmental disorders in patients aged 2 to under 18 years Amber initiation Prescribing guideline Hertfordshire and West Essex ICB
Melatonin Insomnia - product options in adult and paediatric patients with learning disabilities Amber initiation Prescribing guideline Hertfordshire and West Essex ICB
Melatonin Insomnia adults excluding learning disabilities Double Red Decision document Hertfordshire and West Essex ICB
Melatonin (Slenyto) Insomnia Double Red Decision document Hertfordshire and West Essex ICB
Memantine Alzheimer's disease dementia Amber protocol Shared care protocol West Essex
Methylphenidate Attention deficit hyperactivity disorder (ADHD) adult Amber protocol Shared care protocol West Essex
Methylphenidate Attention deficit hyperactivity disorder (ADHD) Amber protocol Shared care protocol East and North Hertfordshire, South and West Hertfordshire
Mexiletine Myotonia in non-dystrophic myotonic disorders (NHSE) Red NICE technology appraisal Hertfordshire and West Essex ICB
Migraine Migraine - chronic Red Prescribing pathway Hertfordshire and West Essex ICB
Migraine Migraine - episodic Red Prescribing pathway Hertfordshire and West Essex ICB
Migraine with or without Aura n/a Clinical pathways Hertfordshire and West Essex ICB
Motor Neurone Disease (MND) n/a Clinical pathways Hertfordshire and West Essex ICB
Multiple Sclerosis (MS) n/a Clinical pathways Hertfordshire and West Essex ICB
Neuropathic Pain Drug Titration and Review n/a Clinical pathways East and North Hertfordshire
Omega 3 fatty acid Primary or secondary prevention of CVD, sleep problems, multiple sclerosis (MS), familial hypercholesterolemia Double Red Prescribing guideline Hertfordshire and West Essex ICB
Open MRI n/a Clinical policy Hertfordshire and West Essex ICB
Open Mri Prior Approval Form n/a Prior approval form Hertfordshire and West Essex ICB
Opioid Pain - long-term prescribing for non-cancer, chronic pain in adults Double Red Position statement Hertfordshire and West Essex ICB
Opioid Pain - persistent self care n/a Prescribing guideline Hertfordshire and West Essex ICB
Opioid Pain - plan agreement n/a Patient information Hertfordshire and West Essex ICB
Opioid Pain - review letter n/a Primary Care prescribing resource Hertfordshire and West Essex ICB
Opioid Aware Campaign n/a Primary Care prescribing resource Hertfordshire and West Essex ICB
Opioid Prescribing Position Statement Pain n/a Position statement Hertfordshire and West Essex ICB
Opioid reduction Opioid reduction tool n/a Primary Care prescribing resource Hertfordshire and West Essex ICB
Oxycodone and naloxone Pain Double Red Prescribing guideline Hertfordshire and West Essex ICB
Paracetamol and tramadol Pain Double Red Prescribing guideline Hertfordshire and West Essex ICB
Peginterferon All indication Red Decision document Hertfordshire and West Essex ICB
Pentosan polysulfate sodium Bladder pain syndrome Red NICE technology appraisal Hertfordshire and West Essex ICB
Pitolisant Excessive daytime sleepiness caused by obstructive sleep apnoea Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Prednisolone All indications - soluble tablet n/a Patient information Hertfordshire and West Essex ICB
Prednisolone enteric coated All indications Double Red n/a Hertfordshire and West Essex ICB
Promethazine All indications Green Position statement Hertfordshire and West Essex ICB
Rapid Onset Isolated Visual Loss (No other neurological symptoms or signs) n/a Clinical pathways Hertfordshire and West Essex ICB
Riluzole Amyotrophic Lateral Sclerosis (ALS) form of Motor Neurone Disease (MND) Amber protocol Shared care protocol Hertfordshire and West Essex ICB
Rimegepant Migraine - prevention Red NICE technology appraisal Hertfordshire and West Essex ICB
Rimegepant Migraine - treating Green NICE technology appraisal Hertfordshire and West Essex ICB
Rivastigmine Alzheimer's disease dementia Amber protocol Shared care protocol West Essex
Shared care Attention deficit hyperactivity disorder (ADHD) by Private Provider Amber protocol Primary Care prescribing resource Hertfordshire and West Essex ICB
Sodium oxybate Narcolepsy with cataplexy (tertiary centre only) Red Prescribing pathway Hertfordshire and West Essex ICB
Solriamfetol Excessive daytime sleepiness caused by narcolepsy (tertiary centre only) Red NICE technology appraisal Hertfordshire and West Essex ICB
Solriamfetol apnoea Excessive daytime sleepiness caused by obstructive sleep apnoea Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Spinal Cord Stimulation n/a Clinical policy Hertfordshire and West Essex ICB
Stroke n/a Clinical pathways Hertfordshire and West Essex ICB
Teriflunomide Relapsing–remitting multiple sclerosis (NHSE) Red NICE technology appraisal Hertfordshire and West Essex ICB
TIA (Transient Ischemic Attack) n/a Clinical pathways East and North Hertfordshire
Transcranial Magnetic Stimulation (TMS and rTMS) n/a Clinical policy Hertfordshire and West Essex ICB
Tremor in Primary Care |Initial Assessment n/a Clinical pathways Hertfordshire and West Essex ICB